drugset / Trial / NCT02330640
A Single-center, Prospective,Randomized Study of Antiplatelet Effects of Ticagrelor Versus Clopidogrel in Patients With Dual Anti-platelet Therapy After Coronary Artery Bypass Grafting
RandomizedParallel-groupSingle-blindTreatment
Summary
This study is designed to demonstrate that the onset of the antiplatelet effect of 90mg bid dose ticagrelor is more rapid and greater than 75 mg qd dose clopidogrel in patients undergoing CABG surgery.
Timeline
- Start
- 2016-01
- Primary completion
- 2016-10
- Completion
- 2016-10-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Clopidogrel | Small molecule | 75 mg | — |
| Subject | Ticagrelor | Small molecule | 90 mg | Oral |
| Background | Aspirin | Small molecule | 100 mg | — |
Indications
No indication recorded.